Conditions: Atopic Dermatitis
Keywords: Atopic eczema Skin Diseases
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 103
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether QAW039 is safe and has beneficial effects in people who have moderate to severe atopic dermatitis (AD).

Detailed description:

Arms:
arm 1: Participants received QAW039 450 mg daily by mouth. arm 2: Participants received matching placebo to QAW039.

Interventions: intervention 1: QAW039 intervention 2: Placebo
Intervention descriptions: intervention 1: Capsules intervention 2: Capsules

Protocol document: